June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Identification of a novel mutation in the PRCD gene causing autosomal recessive retinitis pigmentosa in a Turkish family
Author Affiliations & Notes
  • Ditta Zobor
    Institute for Ophthalmic Research, Centre for Ophthalmology, Tuebingen, Germany
  • Johanna Pach
    Institute for Ophthalmic Research, Centre for Ophthalmology, Tuebingen, Germany
  • Florian Gekeler
    Institute for Ophthalmic Research, Centre for Ophthalmology, Tuebingen, Germany
  • Susanne Kohl
    Institute for Ophthalmic Research, Moleculat Genetics Laoboratory, Tübingen, Germany
  • Footnotes
    Commercial Relationships Ditta Zobor, None; Johanna Pach, None; Florian Gekeler, Retina Implant AG (F), Okuvision GmbH (F), Retina Implant AG (C), Retina Implant AG (P); Susanne Kohl, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 656. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ditta Zobor, Johanna Pach, Florian Gekeler, Susanne Kohl; Identification of a novel mutation in the PRCD gene causing autosomal recessive retinitis pigmentosa in a Turkish family. Invest. Ophthalmol. Vis. Sci. 2013;54(15):656.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Progressive rod-cone degeneration (PRCD) is a canine form of autosomal recessive photoreceptor degeneration and serves as an animal model for human retinitis pigmentosa (RP). To date only two RP-causing mutations of the PRCD gene have been reported in humans. We found a novel homozygous nonsense mutation in PRCD (c.52C>T, p.R18X) in three siblings affected by RP and present detailed morphologic and functional parameters.

Methods: Complete ophthalmological examination was performed including psychophysical tests (ETDRS visual acuity, Lanthony Panel D-15 color vision test and visual field) and electrophysiology (Ganzfeld and multifocal ERG). Additionally, color and infrared fundus photography, autofluorescence and spectral domain optical coherence tomography (OCT) recordings were performed.

Results: We identified a novel homozygous mutation in PRCD (c.52C>T, p.R18X) by diagnostic high-throughput panel sequencing. All three patients showed an advanced stage of disease with reduced visual acuity (mean VA: 20/80), small residual visual fields (mean VF for target III4e: 1134.35 deg2) and no recordable electrophysiological responses. Myopia, posterior subcapsular cataract, bone-spicule-like pigmentation and attenuated arterioles were typical findings. Interestingly, bulls eye maculopathy (BEM) due to patchy retinal pigment epithelium (RPE) atrophy was also present in all patients. The mean central retinal thickness (CRT) observed in OCT was 148µm.

Conclusions: The identification of a third mutation in PRCD confirms its role in the pathogenesis of RP. Clinical findings were in line with the morphological changes observed in previous studies. BEM seems to be a hallmark for RP due to mutations in PRCD.

Keywords: 696 retinal degenerations: hereditary • 539 genetics • 507 electrophysiology: clinical  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×